AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Non-small Cell Lung Cancer (NSCLC)

0
Clinical Trials
10
Meta-Analyses
0
PubMed References
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42022377529
Efficacy and Safety of Elemene Injection Combined with Cranial Radiotherapy for Brain Metastases from Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
According to the statistics released by the National Cancer Center in 2022, ther
CRD42020162429
Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor monotherapy for advanced epidermal growth factor receptor mutated non-small cell lung cancer: a systematic review and meta-analysis
Advanced non-small cell lung cancer (NSCLC)
CRD42019135974
Efficacy and safety of six third-generation chemotherapeutic drugs (paclitaxel, docetaxel, vinorelbine, gemcitabine, pemetrexed and nab-paclitaxel) combined with platinum in the treatment of advanced non-small cell lung cancer: a network meta-analysis
Lung cancer is one of the leading causes of cancer-related deaths worldwide, wit
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Non-small Cell Lung Cancer (NSCLC)
🏥 Names
Disease Name
Non-small Cell Lung Cancer (NSCLC)
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Non-small Cell Lung Cancer (NSCLC)
topic type
disease
tcmsp disease id
570

📊 Meta-Analyses

10 · systematic review
CRD42022377529 Efficacy and Safety of Elemene Injection Combined with Cranial Radiotherapy for
→ According to the statistics released by the Nation
CRD42020162429 Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibito
→ Advanced non-small cell lung cancer (NSCLC)
CRD42019135974 Efficacy and safety of six third-generation chemotherapeutic drugs (paclitaxel,
→ Lung cancer is one of the leading causes of cancer
CRD42020213815 Weekly versus three weeks paclitaxel-based chemotherapy regimens in the treatmen
→ The patients with malignant tumors were considered
CRD42023400730 Evidence assessment for clinical efficacy and safety of Chinese herbal injection
→ It was estimated that lung cancer is the most comm
CRD42023400730 Evidence assessment for clinical efficacy and safety of Chinese herbal injection
→ It was estimated that lung cancer is the most comm
CRD42019134892 Compound kushen injection plus platinum-based chemotherapy for stage IIIB/IV non
→ Lung cancer remains the most common cancer and the
CRD42020162177 The Effect of Zilongjin Tablets combined with chemotherapy in the treatment of n
→ In the classification of lung cancer, non-small ce
CRD42020197499 Zilongjin tablet adjunct with chemotherapy for the treatment of non-small cell l
→ Lung cancer is the foremost cause of cancer-relate
CRD42023469721 Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced l
→ According to the Global Cancer Statistics 2020 rep
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables